Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Hp2-1 was associated with a significant risk for celiac disease (P = 0.0006, odds ratio [OR] 1.54, 95% CI 1.20-1.98; prevalence 56.9% in patients vs 46.1% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP234893.RAjVA1GT4aIdRCs053Qswypi-bDrSVzqycbqj5TZjFM6w130_assertion description "[Hp2-1 was associated with a significant risk for celiac disease (P = 0.0006, odds ratio [OR] 1.54, 95% CI 1.20-1.98; prevalence 56.9% in patients vs 46.1% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP234893.RAjVA1GT4aIdRCs053Qswypi-bDrSVzqycbqj5TZjFM6w130_provenance.
• NP427688.RAtQOpCSm_wzUgsnZfHJVAzUzgy1WVcLvKtbpGYvm5ZGA130_assertion description "[Hp2-1 was associated with a significant risk for celiac disease (P = 0.0006, odds ratio [OR] 1.54, 95% CI 1.20-1.98; prevalence 56.9% in patients vs 46.1% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427688.RAtQOpCSm_wzUgsnZfHJVAzUzgy1WVcLvKtbpGYvm5ZGA130_provenance.
• NP634320.RAPnNqgvmCgHYZVcyW2qF1ZdJCe8BPc5pYWfD_-TUYIE8130_assertion description "[Hp2-1 was associated with a significant risk for celiac disease (P = 0.0006, odds ratio [OR] 1.54, 95% CI 1.20-1.98; prevalence 56.9% in patients vs 46.1% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634320.RAPnNqgvmCgHYZVcyW2qF1ZdJCe8BPc5pYWfD_-TUYIE8130_provenance.
• NP648139.RAEtI49t-75_vuBEns8gDMv0fcdGsxLnixKIvC2XZIOE8130_assertion description "[Hp2-1 was associated with a significant risk for celiac disease (P = 0.0006, odds ratio [OR] 1.54, 95% CI 1.20-1.98; prevalence 56.9% in patients vs 46.1% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648139.RAEtI49t-75_vuBEns8gDMv0fcdGsxLnixKIvC2XZIOE8130_provenance.
• NP575684.RAO15pnbcCagM39H93kTsIQNtiLN_wfkqzUlijoLflIAc130_assertion description "[Hp2-1 was associated with a significant risk for celiac disease (P = 0.0006, odds ratio [OR] 1.54, 95% CI 1.20-1.98; prevalence 56.9% in patients vs 46.1% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575684.RAO15pnbcCagM39H93kTsIQNtiLN_wfkqzUlijoLflIAc130_provenance.
• NP983614.RAfP03rOVCLEOK4EP8ja6xcdBlPLXHRjy2YDLLoEmnbWY130_assertion description "[Hp2-1 was associated with a significant risk for celiac disease (P = 0.0006, odds ratio [OR] 1.54, 95% CI 1.20-1.98; prevalence 56.9% in patients vs 46.1% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP983614.RAfP03rOVCLEOK4EP8ja6xcdBlPLXHRjy2YDLLoEmnbWY130_provenance.
• NP968608.RAfGpEwXh7sB_XEn4hoqTWMPLdAZYMTCG8U4V4nczvMoo130_assertion description "[Hp2-1 was associated with a significant risk for celiac disease (P = 0.0006, odds ratio [OR] 1.54, 95% CI 1.20-1.98; prevalence 56.9% in patients vs 46.1% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968608.RAfGpEwXh7sB_XEn4hoqTWMPLdAZYMTCG8U4V4nczvMoo130_provenance.
• NP654354.RAwbroC2ZsG-Bcbeg-IQcfseaNOw448tnwyEtxGnqLj24130_assertion description "[Hp2-1 was associated with a significant risk for celiac disease (P = 0.0006, odds ratio [OR] 1.54, 95% CI 1.20-1.98; prevalence 56.9% in patients vs 46.1% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654354.RAwbroC2ZsG-Bcbeg-IQcfseaNOw448tnwyEtxGnqLj24130_provenance.
• assertion description "[Hp2-1 was associated with a significant risk for celiac disease (P = 0.0006, odds ratio [OR] 1.54, 95% CI 1.20-1.98; prevalence 56.9% in patients vs 46.1% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP654356.RAmbYBOFZ98O84EUXpaFlIUi7kVVDeeL1RZL8bVNnybio130_assertion description "[Hp2-1 was associated with a significant risk for celiac disease (P = 0.0006, odds ratio [OR] 1.54, 95% CI 1.20-1.98; prevalence 56.9% in patients vs 46.1% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654356.RAmbYBOFZ98O84EUXpaFlIUi7kVVDeeL1RZL8bVNnybio130_provenance.